Viewing Study NCT05100303

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-02-23 @ 4:31 AM
Study NCT ID: NCT05100303
Status: UNKNOWN
Last Update Posted: 2021-10-29
First Post: 2021-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML) View
Keywords: